2022 forecast: AI, Fintiv rule, Arthrex
Arthrex: more unanswered questions
Mark Van Scyoc / Shutterstock.com
The US Patent and Trademark Office (USPTO) is seeking input to help formalise the process that allows the director to review decisions handed down by the Patent Trial and Appeal Board (PTAB).
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
USPTO, Kathi Vidal, PTAB, Arthrex, patents, designs, article of manufacturer, US